United States (USA) Insulin Delivery Devices Market Overview, 2028

In the United States, the increasing prevalence of diabetes has been a significant driver for the insulin delivery device market. As the number of people diagnosed with diabetes continues to rise, the demand for insulin and related delivery devices also increases. On-going advancements in insulin delivery device technology have played a crucial role in driving market growth. Innovations such as smart insulin pens, wearable insulin pumps, and continuous glucose monitoring systems have improved the ease of use, accuracy, and convenience for patients. There is a growing preference among patients for non-invasive or minimally invasive insulin delivery devices. This has led to the development of innovative devices that reduce the discomfort associated with traditional injection methods, such as insulin pumps and patch pumps. The integration of technology for remote patient monitoring and telemedicine has become more prevalent. Insulin delivery devices that are compatible with digital health platforms allow for real-time monitoring and better management of diabetes. The ageing population is more prone to diabetes, and as the demographic of elderly individuals grows, there is a corresponding increase in the demand for insulin and insulin delivery devices. Older individuals may find certain devices more convenient and easier to use, driving the market towards user-friendly solutions. With a trend towards home healthcare and self-management of chronic conditions, there is a growing demand for insulin delivery devices that are user-friendly and allow patients to administer insulin at home without the need for frequent visits to healthcare facilities. Innovations in drug delivery systems, not limited to insulin, can impact the insulin delivery device market. Technologies that enhance the bioavailability and efficacy of insulin may drive the adoption of specific delivery devices. According to the research report "United States Insulin Delivery Devices Market Research Reports," published by Actual Research, the United States Insulin Delivery Devices market was valued more than USD 4 Billion in 2022. The rising incidence of diabetes and the rising cost of healthcare are the main causes of the market's rapid expansion. Furthermore, the market for these improved insulin delivery devices and equipment is expanding as a result of their acceptance. The US market for insulin delivery devices is being driven by significant R&D efforts in the production of several insulin-delivery device types. The United States market is expanding due to factors such as the increasing number of individuals with diabetes and the increased availability of technologically advanced devices. Nearly 29 million Americans suffer with diabetes. In terms of revenue, the North American region accounts for more than one-third of the market for insulin delivery devices. Since diabetes is affecting a greater number of people and is becoming more prevalent in the nation, the market for insulin delivery devices is expanding. Continuous technological advancements in insulin delivery devices have been a prominent trend. This includes the development of smart insulin pens, wearable insulin pumps, and integrated continuous glucose monitoring (CGM) systems. These technologies aim to improve accuracy, convenience, and patient adherence. The integration of AI and data analytics in diabetes management has gained traction. Insulin delivery devices that leverage these technologies can provide insights into patient behavior, predict blood glucose trends, and offer personalized recommendations for insulin dosing. Closed-loop systems, also known as artificial pancreas systems, have been gaining attention. These systems use continuous glucose monitoring and automated insulin delivery to maintain blood glucose levels within a target range. The integration of closed-loop technology into insulin delivery devices is a trend aimed at improving glycemic control and reducing the burden on patients.

What's Inside a Actual Market Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample

Based on product market is segmented into insulin pens, insulin pumps, insulin pen needles, insulin syringes and others insulin delivery devices(insulin transdermal patches, insulin inhalers, insulin jet injection). Among them market is majorly dominated by insulin pens product with significant market share. Insulin pens are designed to offer precise and accurate dosage delivery, enhancing medication adherence for individuals with diabetes. The user-friendly design often includes clear markings and easy-to-read dose indicators, allowing patients to administer insulin with confidence, reducing the risk of dosing errors. The use of short and fine needles in insulin pens contributes to a less painful injection experience for users. This feature is particularly crucial for individuals who may be sensitive to injections or reluctant to undergo frequent injections. The reduced pain associated with insulin pens can enhance patient satisfaction and compliance with prescribed insulin regimens. Insulin pens are available in both reusable and disposable formats, offering patients flexibility in choosing the device that best suits their preferences and lifestyle. Reusable pens are designed to be refilled with insulin cartridges, while disposable pens come pre-filled and are discarded after use. This versatility caters to the diverse needs of the patient population. Based on indication market is divided into diabetes, pregnancy, cardiovascular disorders & hypertension, respiratory diseases, hearing disorders, cancer, movement disorders, wound care and other indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV). The integration of wound care and diabetes management is essential for individuals with diabetic foot ulcers and other related complications. Insulin delivery devices that contribute to glycemic control play a crucial role in supporting integrated care approaches aimed at improving overall patient outcomes. Effective wound healing is closely linked to maintaining optimal blood glucose levels in individuals with diabetes. Insulin delivery devices, including pens and pumps, contribute to glycemic control, which, in turn, supports the body's natural healing processes and helps prevent and manage diabetic-related wounds. In addition based on end user market includes home care, hospitals and clinics and others. Hospitals play a crucial role in inpatient diabetes management, especially for individuals with diabetes who require insulin therapy during hospital stays. The use of insulin pumps, pens, and other delivery devices is common in hospitals to ensure precise and timely insulin administration for inpatients. Integrated care models that bring together various healthcare professionals, including endocrinologists, nurses, and primary care physicians, are becoming more prevalent. In such models, hospitals and clinics are likely to adopt comprehensive approaches to diabetes care, including the use of diverse insulin delivery devices. Hospitals and clinics often serve as hubs for education and training programs related to diabetes management. As healthcare professionals are trained on the proper use of insulin delivery devices, they are more likely to integrate these technologies into their clinical practice, contributing to higher adoption rates. Recent developments: • In November 2020, InPen, a smart insulin pen from Medtronic, was introduced with real-time Guardian Connect CGM data integration. This integrated mechanism makes more informed dosing decisions simpler, providing real-time glucose readings and information on insulin doses. The company received help from this product introduction in growing sales and revenue in the market for insulin delivery devices. • In December 2021, Tandem Diabetes state that it aims to triple its client base by the end of 2027 due to the launch of numerous new products. With an increasing number of people with type 1 diabetes, the company projects that its client base will raise by 1 million new patients over the next five years. Leigh Vosseller, the company's CEO, stated that the company anticipates exploding growth from type 1 and type 2 diabetes.

Make this report your own

We're excited to discuss your needs and our solutions. Let's schedule a call.

Ask an Expert

Kripa Shah

Senior Analyst

Considered in this report: • Geography: United States • Historic year: 2017 • Base year: 2022 • Estimated year: 2023 • Forecast year: 2028 Aspects covered in this report: • United States Insulin Delivery Devices market with its value and forecast along with its segments • Various drivers and challenges • On-going trends and developments • Top profiled companies • Strategic recommendation By Product • Insulin Pens • Insulin Pumps • Insulin Pen Needles • Insulin Syringes • Others Insulin Delivery Devices (Insulin transdermal patches, insulin inhalers, insulin jet injection)

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

By Indication • Diabetes • Pregnancy • Cardiovascular Disorders & Hypertension • Respiratory Diseases • Hearing Disorders • Cancer • Movement Disorders • Wound Care By End User • Home Care • Hospitals & Clinics • Others The approach of the report: This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources. Intended audience: This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Insulin Delivery Devices industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.